Skip to main content

Table 1 Baseline characteristics of the patients

From: Validation and modification of existing mortality prediction models for lower gastrointestinal bleeding: a retrospective study

Parameters

Results

Sex (%)

Male: 627 (57.3)

Female: 468 (42.7)

Age, median (range)

68 (19–94)

Comorbidity (%)

Cancer

206 (18.8)

Heart failure

131 (12.0)

Renal failure

136 (12.4)

Chronic pulmonary obstructive disease

32 (2.9)

Liver cirrhosis

118 (10.8)

ASA score

1

645 (58.9)

2

152 (13.8)

3

298 (27.2)

Mental status

Alert

1045 (95.4)

Altered

50 (4.5)

Medication (%)

Antiplatelet

206 (18.8)

Anticoagulant

122 (11.1)

Non-steroidal anti-inflammatory drugs

306 (27.9)

Hospitalization

Day, median (range)

6.00 (1–203)

Intensive care unit

 

n (%)

51 (4.65)

Day, median (range)

3.00 (1–26)

Mortality (%)

All-cause mortality

40 (3.7)

Bleeding-related mortality

23 (2.1)

Non-bleeding-related mortality

17 (1.6)

  1. ASA, American Society of Anesthesiologists